National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

diazooxonorleucine
An L-glutamine diazo analogue amino acid antibiotic isolated from a species of the bacterial genus Streptomyces with potential antineoplastic activity. Diazooxonorleucine inhibits several glutamine-dependent biosynthetic pathways involved in the the syntheses of D-glucosamine phosphate, purines and pyrimidines. This agent inhibits phosphate-activated glutaminase, a key enzyme for the synthesis of releasable glutamine, depleting cells of this essential amino acid and reducing their capacity to proliferate. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:DON
Chemical structure name:6-diazo-5-oxo-L-norleucine



Previous:DHEA mustard, DI-Leu16-IL2 immunocytokine, dianhydrogalactitol, Diastyl, diaziquone
Next:diazoxide, dichloromethotrexate, diclofenac sodium gel, didanosine, didemnin B

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov